Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foster vs Seretide in COPD
NCT01245569Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Apr 2011
- Primary completion
- Mar 2012
- Modality
- Orthosteric Ligands
- Countries
- 10
01
Overview
A Phase 3 trial of beclomethasone dipropionate, formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started Apr 2011; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01245569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01245569.